Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection

Br J Surg. 2023 Mar 30;110(4):498-499. doi: 10.1093/bjs/znac434.

Authors

Felix J Hüttner^{1

2}, Marius Mauch¹, Max Heckler¹, Thilo Hackert¹, Markus W Büchler¹, Pascal Probst^{1

3}, Markus K Diener^{1

4}

Affiliations

¹ Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
² Department of General and Visceral Surgery, Ulm University Hospital, Ulm, Germany.
³ Department of Surgery, Cantonal Hospital Thurgau, Frauenfeld, Switzerland.
⁴ Department of General and Visceral Surgery, University Medical Centre Freiburg, Freiburg, Germany.

PMID: 36726045
DOI: 10.1093/bjs/znac434

No abstract available

MeSH terms

Adrenergic beta-Antagonists* / therapeutic use
Humans
Pancreas
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / surgery

Substances

Adrenergic beta-Antagonists